摘要
目的探讨原发性结肠腺癌组织与相应癌旁组织中E-cadherin(E-cad)基因异常甲基化改变及其蛋白表达的特点,以及其与结肠腺癌发生发展的关系。方法分别采用甲基化特异PCR(MSP)和免疫组化SP法检测40例原发性结肠腺癌和相应癌旁组织中E-cad基因甲基化状态及蛋白表达水平,并结合临床资料进行分析。结果结肠腺癌中E-cad甲基化率为70.0%,癌旁组织中为10.0%,两者有显著差异性(P<0.01);结肠腺癌中E-cad蛋白的表达率为32.5%,癌旁组织中为80.0%;两者有显著差异性(P<0.01)。E-cad蛋白缺失的27例标本中有24例甲基化阳性,甲基化与蛋白缺失有明显关系(P<0.01)。E-cad甲基化程度与患者的性别、年龄、肿瘤的大小之间差异无显著意义(P>0.05),但与肿瘤浸润深度、分化程度、淋巴结转移之间差异有显著意义(P<0.05)。结论E-cad基因的异常甲基化可影响蛋白的表达,它们与结肠腺癌的发生发展有关,E-cad甲基化和蛋白表达可能作为结肠腺癌预后的候选标志物之一。
Objective To investigate the methylation of the E-cadherin(E-cad) gene and E-cad protein expression in human colon adenearcinoma and the corresponding tumor-adjacent tissues,and evaluate their role in tumor carcinogenesis, and progression and its clinical significance.Methods Methylation-specific PCR (MSP) was used to detect E-cad methylation of 40 parafin-embedded primary colon carcinoma specimens,immunohistochemistry was used to detect the expression of E-cad protein of the correspond- ing tumor-adjacent tissues,and analyze their relations with clinicopathological characteristics.Results The methylation rate was70.0% (28/40)in colon carcinoma and 10.0%(4/40) in corresponding tumor-adjacent tissues.Expression rate of E-cad protein was 32.5% (13/ 40)in colon carcinoma,80.0%(32/40) in corresponding tumor-adjacent tissues.The E-cad gene methylation was closely related to E- cad protein expression in colon carcinoma(P〈0.01 ).The aberrant methylation in the promoter of E-cad gene and the expression of E- cad protein were no relationship with those clinicopathological characteristics: patient's sex,age,the tumor size(P〉0.05) ;but were significantly related to the infiltrating depth, the histological differentiation and lymph node metastasis (P〈0.05). Conclusion Methylation in E-cad gene and E-cad protein expression were associated with the development of colon adenocareinoma and could be used as a putative prognostic indicator for malignancy.
出处
《江西医药》
CAS
2009年第5期430-432,共3页
Jiangxi Medical Journal